Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects

Clinical trial NCT04451954 · COMPLETED

Trial details

NCT number: NCT04451954
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza Immunisation Healthy Volunteers

Start date: 2020-07-02
Primary completion: 2021-09-20
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.